Search

everythinglearnresearchcommunity

for

Search:↓

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Serum triglyceride levels are not linked to prostate cancer risk.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Hair loss gene linked to prostate issues.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Finasteride doesn't harm bone density in older men with BPH.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

PSA can help diagnose high androgen levels in women.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Finasteride may reduce bleeding after TURP, but more research needed.

Fractional lasers could help hair regrowth in androgenic alopecia, but more research is needed to confirm their effectiveness and safety.